Forty-six probands were positive for a coding variant in APP, PSEN1, or PSEN2, including 39 individuals with known pathogenic mutations, 6 with variants of unknown pathogenic significance, and 1 variant that was determined to be an AD risk factor. The gene discussed is APP; the disease is Alzheimer disease.